Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Public health. --- Health surveys.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Public health

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Профилите на държавите по отношение на рака определят силните страни, предизвикателствата и специфичните области на действие за всяка от 27-те държави -- членки на ЕС, Исландия и Норвегия, за да насочват инвестициите. и интервенциите на европейско, национално и регионално равнище в рамките на европейския план за борба с рака. Всеки национален профил по отношение на рака представя в синтезиран вид: болестния товар на онкологичните заболявания в страната; тенденциите по отношение на рисковите фактори за рак (с акцент върху факторите свързани с поведението и околната среда) ; програмите за ранно откриване на онкологичните заболявания; ефективността на онкологичните грижи, с фокус върху достъпността (качеството на грижите, разходите и въздействието на COVID-19 върху грижите за пациентите с рак).

Medical care --- Public health.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Urgent steps are needed to arrest the rising human toll and economic strain from the COVID-19 pandemic that are exacerbating already-diverging recoveries. Pandemic policy is also economic policy as there is no durable end to the economic crisis without an end to the health crisis. Building on existing initiatives, this paper proposes pragmatic actions at the national and multilateral level to expeditiously defeat the pandemic. The proposal targets: (1) vaccinating at least 40 percent of the population in all countries by the end of 2021 and at least 60 percent by the first half of 2022, (2) tracking and insuring against downside risks, and (3) ensuring widespread testing and tracing, maintaining adequate stocks of therapeutics, and enforcing public health measures in places where vaccine coverage is low. The benefits of such measures at about $9 trillion far outweigh the costs which are estimated to be around $50 billion—of which $35 billion should be paid by grants from donors and the residual by national governments potentially with the support of concessional financing from bilateral and multilateral agencies. The grant funding gap identified by the Access to COVID-19 Tools (ACT) Accelerator amounts to about $22 billion, which the G20 recognizes as important to address. This leaves an estimated $13 billion in additional grant contributions needed to finance our proposal. Importantly, the strategy requires global cooperation to secure upfront financing, upfront vaccine donations, and at-risk investment to insure against downside risks for the world.

Macroeconomics --- Economics: General --- Diseases: Contagious --- Demography --- Industries: Manufacturing --- Publicly Provided Goods: General --- Health: General --- Economic Growth and Aggregate Productivity: General --- Industry Studies: Manufacturing: General --- Health Behavior --- Demographic Economics: General --- Aggregate Factor Income Distribution --- Economic & financial crises & disasters --- Economics of specific sectors --- Infectious & contagious diseases --- Health economics --- Population & demography --- Manufacturing industries --- Financial crises --- Economic sectors --- Health --- Population and demographics --- National accounts --- Crisis management --- Natural disasters --- Communicable diseases --- Population --- Income --- India